- Investing Ideas
- /
- Canadian Pharmaceuticals & Biotech Financially Fit Penny Stocks
Canadian Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
48
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
48 companies
Decibel Cannabis
Market Cap: CA$31.7m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.055
7D
-8.3%
1Y
-60.7%
Planet 13 Holdings
Market Cap: CA$110.6m
Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.
PLTH
CA$0.34
7D
36.0%
1Y
-64.2%
Covalon Technologies
Market Cap: CA$64.2m
Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.
COV
CA$2.34
7D
-4.9%
1Y
112.7%
Captor Capital
Market Cap: CA$2.0m
Engages in the retail sale of cannabis products in the United States.
CPTR
CA$0.59
7D
-4.8%
1Y
-28.5%
Oncolytics Biotech
Market Cap: CA$60.5m
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.
ONC
CA$0.88
7D
25.7%
1Y
-42.9%
Rubicon Organics
Market Cap: CA$26.7m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada.
ROMJ
CA$0.47
7D
-11.3%
1Y
17.5%
TerrAscend
Market Cap: CA$133.3m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$0.38
7D
-26.5%
1Y
-84.8%
Satellos Bioscience
Market Cap: CA$104.5m
A biotechnology company, develops regenerative therapeutics to treat degenerative muscle diseases primarily in Canada and Australia.
MSCL
CA$0.63
7D
-3.1%
1Y
23.5%
Microbix Biosystems
Market Cap: CA$50.2m
A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.
MBX
CA$0.35
7D
-13.4%
1Y
0%
XORTX Therapeutics
Market Cap: CA$4.4m
A late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, pre-diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection.
XRTX
CA$1.15
7D
-10.2%
1Y
-75.1%
Crescita Therapeutics
Market Cap: CA$10.1m
A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.
CTX
CA$0.53
7D
-5.4%
1Y
26.2%
Cronos Group
Market Cap: CA$929.5m
Operates as a cannabinoid company that engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
CRON
CA$2.43
7D
0%
1Y
-29.6%
Medicenna Therapeutics
Market Cap: CA$70.4m
An immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases.
MDNA
CA$0.90
7D
0%
1Y
-54.1%
Innovotech
Market Cap: CA$7.0m
Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.
IOT
CA$0.14
7D
3.7%
1Y
7.7%
High Tide
Market Cap: CA$226.6m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$2.80
7D
8.5%
1Y
-10.8%
Rakovina Therapeutics
Market Cap: CA$7.7m
A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.
RKV
CA$0.055
7D
-42.1%
1Y
-38.9%
Telo Genomics
Market Cap: CA$9.0m
A molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada.
TELO
CA$0.10
7D
0%
1Y
-51.2%
Verano Holdings
Market Cap: CA$265.6m
Operates as a vertically integrated multi-state cannabis operator in the United States.
VRNO
CA$0.74
7D
1.4%
1Y
-89.4%
RAMM Pharma
Market Cap: CA$1.8m
Engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland.
RAMM
CA$0.015
7D
0%
1Y
-75.0%
MediPharm Labs
Market Cap: CA$35.3m
A pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.
LABS
CA$0.085
7D
-5.6%
1Y
6.3%
Vaxil Bio
Market Cap: CA$1.4m
A biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer.
VXL
CA$0.01
7D
0%
1Y
0%
Entheon Biomedical
Market Cap: CA$1.8m
Operates as a biotechnology research and development company.
ENBI
CA$0.13
7D
23.8%
1Y
0%
Avant Brands
Market Cap: CA$11.4m
Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.
AVNT
CA$0.97
7D
-4.9%
1Y
-64.1%
Thiogenesis Therapeutics
Market Cap: CA$25.5m
A biopharmaceutical company, develops thiol-active therapeutic compounds to treat unmet pediatric medical needs.
TTI
CA$0.56
7D
-13.8%
1Y
-25.3%
Psyence Group
Market Cap: CA$2.1m
A life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom.
PSYG
CA$0.015
7D
0%
1Y
-25.0%
Voyageur Pharmaceuticals
Market Cap: CA$30.5m
Engages in the acquiring, exploring, and developing raw materials for pharmaceutical products in the province of British Columbia, Canada, and the state of Utah.
VM
CA$0.19
7D
2.7%
1Y
192.3%
Cardiol Therapeutics
Market Cap: CA$102.4m
A clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.31
7D
10.1%
1Y
-48.6%
Eupraxia Pharmaceuticals
Market Cap: CA$148.4m
A clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector.
EPRX
CA$4.14
7D
-0.2%
1Y
11.9%
Blueberries Medical
Market Cap: CA$7.4m
Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.
BBM
CA$0.015
7D
50.0%
1Y
n/a
Trulieve Cannabis
Market Cap: CA$890.1m
Operates as a cannabis retailer.
TRUL
CA$4.66
7D
2.4%
1Y
-69.9%
Steep Hill
Market Cap: CA$970.7k
Does not have significant operations.
STPH
CA$0.06
7D
0%
1Y
140.0%
NurExone Biologic
Market Cap: CA$53.8m
Operates as a pharmaceutical technology company.
NRX
CA$0.69
7D
3.0%
1Y
6.2%
Telescope Innovations
Market Cap: CA$15.6m
A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.
TELI
CA$0.29
7D
-10.8%
1Y
-19.4%
Ayurcann Holdings
Market Cap: CA$4.9m
Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.
AYUR
CA$0.025
7D
-16.7%
1Y
-37.5%
Vireo Growth
Market Cap: CA$194.6m
Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.
VREO
CA$0.53
7D
-11.7%
1Y
-3.6%
InnoCan Pharma
Market Cap: CA$55.3m
A pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally.
INNO
CA$0.17
7D
0%
1Y
-41.4%